Del Rosso J, Yosipovitch G, Ständer S, Silverberg J, Wollenberg A, Lio PA, Carrascosa JM, Gallo G, Casillas M, Pierce E, Ding Y, Xu Z, Agell H, Stein Gold L. Lebrikizumab Provides Stable Itch Response With No or Minimal Fluctuations up to One Year in Patients With Atopic Dermatitis. J of Skin [Internet]. 2023Nov.13 [cited 2024Sep.20];7(6):s282. Available from: https://dermsquared.com/skin/article/view/2390